+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Multidrug Resistant Acinetobacter Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Multidrug Resistant Acinetobacter Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Rotavirus infections - Pipeline Insight, 2024 - Product Thumbnail Image

Rotavirus infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2024 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 75 Pages
  • Global
From
Schistosomiasis - Pipeline Insight, 2024 - Product Thumbnail Image

Schistosomiasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Community-acquired pneumonia (CAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Community-acquired pneumonia (CAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
West Nile - Pipeline Insight, 2024 - Product Thumbnail Image

West Nile - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Helicobacter Pylori Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Helicobacter Pylori Infection - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
SER-109 Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SER-109 Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
REBYOTA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REBYOTA Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Vancomycin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Vancomycin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Metronidazole Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Metronidazole Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
Surgical Site Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Surgical Site Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bone Marrow Transplant Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Bone Marrow Transplant Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more